Alloy built its menopause telehealth practice around a subscription model with asynchronous intake. It’s the budget-friendly option that works well for straightforward cases.
What they do
Menopause-trained clinicians review your medical history and symptom questionnaire asynchronously, then prescribe. HRT, vaginal estrogen, and some non-hormonal options. Delivery of medications handled directly.
What sets them apart
- Flat monthly subscription — roughly $49/month plus medication
- No live video required for most visits
- Free follow-ups included
- Straightforward formulary of evidence-backed options
What community reports
“Subscription pricing works for my budget. The asynchronous intake was fine for what I needed. If you want to actually talk to a clinician on live video, this isn’t set up for that.”
Pricing
- Approximately $49/month subscription
- Medication cost additional
- No insurance billing
- Cheaper overall than most alternatives for women on HRT long-term
Who it’s best for
- Women with clear menopause symptoms who don’t need extensive live discussion
- Budget-conscious women who’ll be on HRT long-term
- Women comfortable with asynchronous clinical interaction
Who might prefer alternatives
- Women wanting a live video visit with their prescriber (Midi or Winona)
- Women with complex histories requiring nuanced real-time discussion
- Women wanting broad non-hormonal options (Midi has wider formulary)
The honest summary
Alloy is a solid fit for women whose menopause picture is straightforward and who value price and convenience over a live clinician relationship. The asynchronous model keeps costs down and works efficiently — but you give up some conversational depth.